Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD

Circulation. 2024 May 7;149(19):1536-1539. doi: 10.1161/CIRCULATIONAHA.124.068080. Epub 2024 May 6.

Justin T Morrison^#^{1

2}, Mario Enrico Canonico^#^{1

2}, Sonia S Anand³, Manesh R Patel⁴, Eike Sebastian Debus⁵, Mark R Nehler^{1

6}, Connie N Hess^{1

2}, Judith Hsia^{1

2}, Warren H Capell^{1

7}, Eva Muehlhofer⁸, Lloyd P Haskell⁹, Scott D Berkowitz^{1

2

10}, Rupert M Bauersachs^{11

12}, Marc P Bonaca^{1

2}

¹ Colorado Prevention Center Clinical Research, Aurora, CO (J.T.M., M.E.C., M.R.N., C.N.H., J.H., W.H.C., S.D.B., M.P.B.).
² Division of Cardiology (J.T.M., M.E.C., C.N.H., J.H., S.D.B., M.P.B.), University of Colorado School of Medicine, Aurora.
³ Population Health Research Institute, Hamilton Health Sciences, Department of Medicine, McMaster University, Canada (S.S.A.).
⁴ Duke Clinical Research Institute, Division of Cardiology, Duke University Medical Center, Durham, NC (M.R.P.).
⁵ Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Germany (E.S.B.).
⁶ Department of Medicine, Department of Surgery (M.R.N.), University of Colorado School of Medicine, Aurora.
⁷ Division of Endocrinology (W.H.C.), University of Colorado School of Medicine, Aurora.
⁸ Bayer AG Research and Development, Pharmaceuticals, Wuppertal, Germany (E.M.).
⁹ Janssen Research and Development, Raritan, NJ (L.P.H.).
¹⁰ Division of Hematology (S.D.B.), University of Colorado School of Medicine, Aurora.
¹¹ Cardioangiologic Center, Agaplesion Bethanien Hospital, Frankfurt am Main, Germany (R.M.B.).
¹² Center for Thrombosis and Hemostasis, University of Mainz, Germany (R.M.B.).

^# Contributed equally.

No abstract available

Keywords: cardiovascular diseases; coronary artery disease; peripheral artery disease; rivaroxaban.

Publication types